Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Ovarian Adenocarcinoma · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Invasive Malignant Neoplasm
Invasive Carcinoma
Ovarian Carcinoma
Ovarian Adenocarcinoma

Subtype

Ovarian Adenocarcinoma

CI-CAN-00006216Explore in graph →

83 active trials1 approved drugs8 evidence items

NCIt: C7700

Overview
Statistics
Survival
Genomics8
Variants & evidence8
Drugs7
Trials183
Research
Rankings
Sources & provenance

Data completeness5 / 7 dimensions

Epidemiology (no data yet)
Survival (no data yet)
Trials (data present)
Literature (data present)
Genomics (data present)
Evidence (data present)
Therapies (data present)

Computed from entity_counters.completeness · refreshed after each connector run

Definition

What this entity is

An adenocarcinoma that arises from the ovary. It is the most common type of ovarian carcinoma. It includes the serous adenocarcinoma, mucinous adenocarcinoma, clear cell adenocarcinoma, and endometrioid adenocarcinoma.

Definition text as published by ncit-evsProvenance

Source: NCI Thesaurus (NCIt)
Dataset: NCI Thesaurus
Version: 26.08e
Retrieved: Sep 8, 2026
Layer: raw (as published)
Evidence: expert curation
License: CC BY 4.0
Run: ING-NCITEVS-20260908-000001

Open at source Curated

Data updated 22 days agoSource updated 26.08e

Taxonomy

Position in the hierarchies

Several hierarchies coexist; edges are listed per hierarchy type with their source.

Parents

ncit

Female Reproductive System AdenocarcinomaSubtype
Ovarian CarcinomaSubtype

Children (8)

ncit

Ovarian Clear Cell Adenocarcinoma2 sub
Ovarian Cystadenocarcinoma3 sub
Ovarian Endometrioid Adenocarcinoma5 sub
Ovarian Mesonephric-Like Adenocarcinoma
Ovarian Mixed Cell Adenocarcinoma
Ovarian Mucinous Adenocarcinoma2 sub
Ovarian Serous Adenocarcinoma6 sub
Ovarian Signet Ring Cell Adenocarcinoma

Anatomy

Anatomical sites

AdnexalC212119
Genitourinary SystemC156482

Record

Identity

CancerIndex ID: CI-CAN-00006216
Entity type: Subtype
Malignant: Yes
Solid / hematologic: Solid tumor
Pediatric relevant: Not flagged
Rare cancer: Unknown (no incidence data yet)
Hierarchy depth: 6
Classification version: 26.08e
Semantic types: Neoplastic Process
Status: Active
Record updated: 2026-09-08

Coverage

Data completeness

Trials (all / active)

29 descendants in total; counters on this page aggregate over all of them.

183 / 83

Publications (all / 5y)

1,623 / 227

Evidence items

8

Genes / variants

119 / 8

Drugs (any / approved)

7 / 1

Genomic cohorts

8

Epidemiology / survival obs.

0 / 0

Data updated 18 hours agoSource updated unknowncounters aggregate over descendants

Names

Synonyms (2)

Adenocarcinoma of Ovarysynonym · NCIt
Adenocarcinoma of the Ovarysynonym · NCIt

CancerIndex is a research and information platform. It does not diagnose and does not recommend treatment.

Key figures

At a glance

Each figure carries its unit, period and source; ranks link to "Why this rank?".

US deaths12,654countUnited States · 2024 · both sexes · all agescdc-wonderObservedrank #14 of 31 (USA · both sexes · all ages · 2024 · top-level cancers)figures shown for Malignant Ovarian Neoplasm (registry level) — open Malignant Ovarian Neoplasm
US new cases21,112countUnited States · 2023 · both sexes · all agescdc-uscsObservedrank #18 of 32 (USA · both sexes · all ages · 2023 · top-level cancers)figures shown for Malignant Ovarian Neoplasm (registry level) — open Malignant Ovarian Neoplasm
US age-standardized mortality2.9per 100,000United States · 2024 · both sexes · all ages · 2000 U.S. Std. Populationcdc-wonderObservedrank #5 of 28 (USA · Female · all ages · 2024 · top-level cancers)figures shown for Malignant Ovarian Neoplasm (registry level) — open Malignant Ovarian Neoplasm
Active trials83countcurrent registry status · entity + descendantsclinicaltrialsComputedrank #213 of 1,654 (World · both sexes · all ages · latest · all malignant entities)
Recruiting trials38countstatus RECRUITING · entity + descendantsclinicaltrialsComputedrank #228 of 1,277 (World · both sexes · all ages · latest · all malignant entities)
Curated evidence items8countaccepted CIViC items · entity + descendantscivicComputedrank #213 of 492 (World · both sexes · all ages · latest · all malignant entities)
Publications, last 12 months45countPubMed records · stored query · 12-month windowpubmedComputedrank #476 of 2,294 (World · both sexes · all ages · latest · all malignant entities)
Genomic cohorts8countopen GDC projects · entity + descendantsgdcComputedrank #119 of 296 (World · both sexes · all ages · latest · all malignant entities)

Data updated 18 hours agoSource updated unknownregistry figures: cdc-wonder · latest year available per metric · counters aggregate over descendants